Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Re-Appointment of Statutory Auditor & Appoinment of Secretarial Auditor of the company w.e.f. September 03, 2025 subject to approval of Shareholders in the ensuing Annual General Meeting
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed the stock exchange about the re-appointment of its Statutory Auditor and the appointment of a Secretarial Auditor, both effective from September 03, 2025. These appointments are subject to approval from shareholders at the upcoming Annual General Meeting. Re-appointment of the statutory auditor is a routine compliance requirement typically done for a five-year term under the Companies Act. The addition of a Secretarial Auditor strengthens corporate governance and compliance reporting. No details on the names of the audit firms or the tenure were disclosed in this filing.
This is a routine governance and compliance-related announcement with no material impact on the company's financials or operations. Shareholders will have the opportunity to approve or reject these appointments at the AGM, which is standard procedure.